Loading clinical trials...
Loading clinical trials...
The Thromboxane Receptor Antagonist to Block the Effects of Non-Platelet Thromboxane Generation and Improve Endothelial Function (TRAP) Trial
Conditions
Interventions
Ifetroban Sodium
Placebo
Locations
1
United States
University of Massachusetts Medical School
Worcester, Massachusetts, United States
Start Date
September 20, 2019
Primary Completion Date
November 7, 2022
Completion Date
November 15, 2022
Last Updated
December 5, 2024
NCT07547098
NCT07487363
NCT06909773
NCT06505109
NCT06189313
NCT06706206
Lead Sponsor
Jeffrey Rade
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions